Search
Biote Corp
BTMDAdd to Watchlist
1.300USD
-0.020-1.52%
Close 09-23 16:00（ET）
48.85MMarket Cap
2.59P/E TTM
About Biote Corp Company
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Biote Corp Profile
Ticker SymbolBTMD
Company nameBiote Corp
IPO dateMar 02, 2021
CEOChristensen (Bret)
Number of employees217
Security typeOrdinary Share
Fiscal year-endMar 02
Address1875 W. Walnut Hill Ln #100
CityIRVING
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code75038
Phone19724869346
Websitehttps://haymakeracquisition.com/
Ticker SymbolBTMD
IPO dateMar 02, 2021
CEOChristensen (Bret)
Company Executives of Biote Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
239.74K
+55.04%
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
239.74K
+55.04%
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
239.74K
+55.04%
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Bret Christensen
Mr. Bret Christensen
Director
Director
37.59K
--
Mr. Bret Christensen
Mr. Bret Christensen
Director
Director
37.59K
--
Mr. Bret Christensen
Mr. Bret Christensen
Director
Director
37.59K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
239.74K
+55.04%
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
239.74K
+55.04%
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
239.74K
+55.04%
FAQs
Who are the top five shareholders of Biote Corp?
The top five shareholders of Biote Corp are: Mr. Andrew R. (Andy) Heyer
How many institutions hold shares of Biote Corp (BTMD)?
As of 2026Q1, 214 institutions hold shares of Biote Corp, with a combined market value of approximately 20.55M, accounting for 64.13% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -2349533.00.
What is the biggest source of revenue for Biote Corp?
In 2026Q1, the Pellet Procedures business generated the highest revenue for Biote Corp, amounting to 30.31M and accounting for 68.52% of total revenue.